AstraZeneca slumps on report CEO is heading to Teva

LONDON (Reuters) - Shares in AstraZeneca fell more than 5 percent on Thursday after a media report said Chief Executive Pascal Soriot was about to defect to Israel-based Teva Pharmaceutical Industries.

from Reuters: Top News http://uk.reuters.com/article/uk-teva-pharm-ind-astrazeneca-ceo-idUKKBN19Y0QO?feedType=RSS&feedName=topNews